个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Depletion of squalene epoxidase in synergy with glutathione peroxidase 4 inhibitor RSL3 overcomes oxidative stress resistance in lung squamous cell carcinoma

| 认领 | 导出 | |

文献详情

资源类型：
Pubmed体系：
作者：
Li Guo[1,2] * ; Chen Lu[2] * ; Bai Hua[1] ; Zhang Li[2,3,4,5] ; Wang Jie[1] ; Li Weimin[2,3,4,5,6] ;
机构： [1]CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Beijing 100021, China. [2]Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China. [3]Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China. [4]Precision Medicine Center, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu 610041, China. [5]State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Chengdu 610041, China. [6]The Research Units of West China, Chinese Academy of Medical Sciences, West China Hospital, Chengdu 610041, China.
出处：
DOI： 10.1093/pcmedi/pbae011
ISSN：

关键词： lung squamous cell carcinoma squalene epoxidase terbinafine ROS ferroptosis

摘要：
Lung squamous cell carcinoma (LUSC) lacks effective targeted therapies and has a poor prognosis. Disruption of squalene epoxidase (SQLE) has been implicated in metabolic disorders and cancer. However, the role of SQLE as a monooxygenase involved in oxidative stress remains unclear.We analyzed the expression and prognosis of lung adenocarcinoma (LUAD) and LUSC samples from GEO and TCGA databases. The proliferative activity of the tumors after intervention of SQLE was verified by cell and animal experiments. JC-1 assay, flow cytometry, and Western blot were used to show changes in apoptosis after intervention of SQLE. Flow cytometry and fluorescence assay of ROS levels were used to indicate oxidative stress status.We investigated the unique role of SQLE expression in the diagnosis and prognosis prediction of LUSC. Knockdown of SQLE or treatment with the SQLE inhibitor terbinafine can suppress the proliferation of LUSC cells by inducing apoptosis and reactive oxygen species accumulation. However, depletion of SQLE also results in the impairment of lipid peroxidation and ferroptosis resistance such as upregulation of glutathione peroxidase 4. Therefore, prevention of SQLE in synergy with glutathione peroxidase 4 inhibitor RSL3 effectively mitigates the proliferation and growth of LUSC.Our study indicates that the low expression of SQLE employs adaptive survival through regulating the balance of apoptosis and ferroptosis resistance. In future, the combinational therapy of targeting SQLE and ferroptosis could be a promising approach in treating LUSC.© The Author(s) 2024. Published by Oxford University Press on behalf of the West China School of Medicine & West China Hospital of Sichuan University.

基金：
This work was supported by the National Natural Science Foundation of China (Grant No. 92159302, W.L.); Science and Technology Project of Sichuan (Grant No. 2022ZDZX0018, W.L.); 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (Grant No. ZYGD22009, W.L.). This work was also supported by National Key R&D program of China (Grant No. 2022YFC2505000), NSFC general program (Grant No. 82272796), NSFC special program (Grant No. 82241229), CAMS Innovation Fund for Medical Sciences (Grant No. CIFMS 2022-I2M-1–009), CAMS Key Laboratory of Translational Research on Lung Cancer (Grant No. 2018PT31035), and the Aiyou foundation (Grant No. KY201701)
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2024]版：
无
最新[2023]版：
大类 | 4 区 医学
小类 | 4 区 医学：研究与实验
第一作者：
第一作者机构： [1]CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Beijing 100021, China. [2]Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
共同第一作者：
通讯作者：
通讯机构： [2]Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China. [3]Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China. [4]Precision Medicine Center, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu 610041, China. [5]State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Chengdu 610041, China. [6]The Research Units of West China, Chinese Academy of Medical Sciences, West China Hospital, Chengdu 610041, China.
推荐引用方式(GB/T 7714)：
Li Guo,Chen Lu,Bai Hua,et al.Depletion of squalene epoxidase in synergy with glutathione peroxidase 4 inhibitor RSL3 overcomes oxidative stress resistance in lung squamous cell carcinoma[J].Precision Clinical Medicine.2024,7(2):pbae011.doi:10.1093/pcmedi/pbae011.
APA：
Li Guo,Chen Lu,Bai Hua,Zhang Li,Wang Jie&Li Weimin.(2024).Depletion of squalene epoxidase in synergy with glutathione peroxidase 4 inhibitor RSL3 overcomes oxidative stress resistance in lung squamous cell carcinoma.Precision Clinical Medicine,7,(2)
MLA：
Li Guo,et al."Depletion of squalene epoxidase in synergy with glutathione peroxidase 4 inhibitor RSL3 overcomes oxidative stress resistance in lung squamous cell carcinoma".Precision Clinical Medicine 7..2(2024):pbae011

相关文献

[1]Kanglaite alleviates lung squamous cell carcinoma through ferroptosis [2]A Practical Prognostic lncRNA Signature for Lung Squamous Cell Carcinoma [3]Fe-HCOF-PEG2000 as a Hypoxia-Tolerant Photosensitizer to Trigger Ferroptosis and Enhance ROS-Based Cancer Therapy [4]Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma. [5]Bronchial artery chemoembolization with apatinib for treatment of central lung squamous cell carcinoma [6]miRNA-9 Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Regulating NRSF/EGFR [7]Differential contributions of adeno- and squamous components in promoting lymphatic metastasis of lung adenosquamous cell carcinoma [8]NFIX downregulation independently predicts poor prognosis in lung adenocarcinoma, but not in squamous cell carcinoma [9]Utilization of circulating cell-free DNA profiling to guide first-line chemotherapy in advanced lung squamous cell carcinoma(Open Access) [10]Squamous cell lung carcinoma with gastrointestinal metastasis: a case report and review of literature

资源点击量：52808 今日访问量：2 总访问量：4561 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号